Zinat Abdrakhmanova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zinat Abdrakhmanova has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Aigul P. Yermagambetova
WEST KAZAKHSTAN MARAT OSPANOV MEDICAL UNIVERSITY, AKTOBE, REPUBLIC OF KAZAKHSTAN
1 shared publication - Aiman Oksenbayeva
Kazakhstan-Russian Medical University
1 shared publication - Ainur Kumar
Department of Health Policy and Management, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
1 shared publication - Aizhan Raushanova
Department of Epidemiology, Biostatistics and Evidence-Based Medicine, al-Farabi Kazakh National University, Almaty, Kazakhstan
1 shared publication - Akgul Baizullina
WEST KAZAKHSTAN MARAT OSPANOV MEDICAL UNIVERSITY, AKTOBE, REPUBLIC OF KAZAKHSTAN
1 shared publication - Aliya Baidauletova
Al Farabi Kazakh National University, Almaty, Kazakhstan
1 shared publication
Latest Publications
- 30 June 2026
- Published by Semey Medical University in Наука и здравоохранение
- No. 3(28),p. 134-140
EPIDEMIOLOGICAL PATTERNS OF CANCER INCIDENCE IN KOKSHETAU (2014–2024): TRENDS AND RISK ASSESSMENT
Introduction. Cancer remains a leading cause of morbidity and mortality worldwide, representing a serious public health challenge. The situation in Kazakhstan reveals regional differences in cancer incidence and mortality, highlighting the importance of local epidemiological surveillance. The aim of our study is to analyze the ten-year dynamics of cancer incidence among the population of Kokshetau (2014–2024) and develop a predictive model for subsequent years to guide recommendations for reducing incidence. Materials and Methods. A retrospective epidemiological study was conducted using data from official medical registries and regional cancer reports. Descriptive statistics, annual incidence rates per 100,000 population, and sex distribution were calculated. Linear regression and the χ² test were used to assess temporal trends and gender differences. A risk assessment was conducted to identify key demographic and temporal factors determining cancer incidence. Results. From 2014 to 2024, a steady increase in overall cancer incidence was observed. The lowest rate was recorded in 2018, followed by a steady rise, particularly between 2022 and 2024. No statistically significant sex differences were found (p > 0.05 for all years). In 2018, the proportion of males (61.5%) was higher than females (38.5%), but this difference was not statistically significant (χ² = 1.385; p = 0.239). Regression analysis revealed a strong linear trend (R² = 0.5612) indicating continuous growth over the decade. Conclusion. The findings demonstrate a growing cancer burden in Kokshetau, emphasizing the need for enhanced regional screening programs, targeted preventive measures, and improved early diagnostic capacity. The identified trends and risk factors can support evidence-based strategies for cancer control in northern region of Kazakhstan. Введение. Рак на сегодняшний день есть и остается одной из ведущих причин заболеваемости и смертности во всем мире, представляя собой серьезную проблему для общественного здравоохранения. Ситуация в Казахстане представляет региональные различия в заболеваемости и смертности от рака и соответственно подчеркивают важность местного эпидемиологического надзора. Целью нашего исследования является проанализировать десятилетнюю динамику заболеваемости раком среди населения города Кокшетау (2014–2024 гг.) и разработать прогностическую модель для последующих лет для разработки рекомендации по снижению заболеваемости. Материалы и методы. Было проведено ретроспективное эпидемиологическое исследование с использованием данных официальных медицинских регистров и региональных онкологических отчетов. Были рассчитаны описательные статистические показатели, годовые показатели заболеваемости на 100 000 населения и распределение по полу. Для оценки временных тенденций и гендерных различий использовались линейная регрессия и критерий χ². Была проведена оценка риска для выявления ключевых демографических и временных факторов, определяющих заболеваемость раком. Результаты. В период с 2014 по 2024 гг. наблюдался устойчивый рост общей заболеваемости раком. Наименьший показатель был зафиксирован в 2018 году, после чего отмечался стабильный рост, особенно в 2022–2024 гг. Статистически значимых различий по полу выявлено не было (p > 0,05 для всех лет). В 2018 году доля мужчин составила 61,5%, женщин — 38,5%, однако данная разница не была статистически значимой (χ² = 1,385; p = 0,239). По результатам регрессионного анализа выявлен выраженный линейный тренд (R² = 0,5612), указывающий на постоянный рост заболеваемости в течение десятилетия. Выводы. Полученные данные свидетельствуют о растущем бремени онкологических заболеваний в Кокшетау, подчеркивая необходимость усиления региональных программ скрининга, целенаправленных профилактических мер и улучшения возможностей ранней диагностики. Выявленные тенденции и факторы риска могут послужить основой для разработки научно обоснованных стратегий борьбы с раком в северном регионе Казахстана. Кіріспе. Қатерлі ісік бүкіл әлемде аурушаңдық пен өлімнің негізгі себебі болып қала береді, бұл қоғамдық денсаулық...
- 30 June 2026
- Published by Semey Medical University in Наука и здравоохранение
- No. 3(28),p. 134-140
EPIDEMIOLOGICAL PATTERNS OF CANCER INCIDENCE IN KOKSHETAU (2014–2024): TRENDS AND RISK ASSESSMENT
Introduction. Cancer remains a leading cause of morbidity and mortality worldwide, representing a serious public health challenge. The situation in Kazakhstan reveals regional differences in cancer incidence and mortality, highlighting the importance of local epidemiological surveillance. The aim of our study is to analyze the ten-year dynamics of cancer incidence among the population of Kokshetau (2014–2024) and develop a predictive model for subsequent years to guide recommendations for reducing incidence. Materials and Methods. A retrospective epidemiological study was conducted using data from official medical registries and regional cancer reports. Descriptive statistics, annual incidence rates per 100,000 population, and sex distribution were calculated. Linear regression and the χ² test were used to assess temporal trends and gender differences. A risk assessment was conducted to identify key demographic and temporal factors determining cancer incidence. Results. From 2014 to 2024, a steady increase in overall cancer incidence was observed. The lowest rate was recorded in 2018, followed by a steady rise, particularly between 2022 and 2024. No statistically significant sex differences were found (p > 0.05 for all years). In 2018, the proportion of males (61.5%) was higher than females (38.5%), but this difference was not statistically significant (χ² = 1.385; p = 0.239). Regression analysis revealed a strong linear trend (R² = 0.5612) indicating continuous growth over the decade. Conclusion. The findings demonstrate a growing cancer burden in Kokshetau, emphasizing the need for enhanced regional screening programs, targeted preventive measures, and improved early diagnostic capacity. The identified trends and risk factors can support evidence-based strategies for cancer control in northern region of Kazakhstan. Введение. Рак на сегодняшний день есть и остается одной из ведущих причин заболеваемости и смертности во всем мире, представляя собой серьезную проблему для общественного здравоохранения. Ситуация в Казахстане представляет региональные различия в заболеваемости и смертности от рака и соответственно подчеркивают важность местного эпидемиологического надзора. Целью нашего исследования является проанализировать десятилетнюю динамику заболеваемости раком среди населения города Кокшетау (2014–2024 гг.) и разработать прогностическую модель для последующих лет для разработки рекомендации по снижению заболеваемости. Материалы и методы. Было проведено ретроспективное эпидемиологическое исследование с использованием данных официальных медицинских регистров и региональных онкологических отчетов. Были рассчитаны описательные статистические показатели, годовые показатели заболеваемости на 100 000 населения и распределение по полу. Для оценки временных тенденций и гендерных различий использовались линейная регрессия и критерий χ². Была проведена оценка риска для выявления ключевых демографических и временных факторов, определяющих заболеваемость раком. Результаты. В период с 2014 по 2024 гг. наблюдался устойчивый рост общей заболеваемости раком. Наименьший показатель был зафиксирован в 2018 году, после чего отмечался стабильный рост, особенно в 2022–2024 гг. Статистически значимых различий по полу выявлено не было (p > 0,05 для всех лет). В 2018 году доля мужчин составила 61,5%, женщин — 38,5%, однако данная разница не была статистически значимой (χ² = 1,385; p = 0,239). По результатам регрессионного анализа выявлен выраженный линейный тренд (R² = 0,5612), указывающий на постоянный рост заболеваемости в течение десятилетия. Выводы. Полученные данные свидетельствуют о растущем бремени онкологических заболеваний в Кокшетау, подчеркивая необходимость усиления региональных программ скрининга, целенаправленных профилактических мер и улучшения возможностей ранней диагностики. Выявленные тенденции и факторы риска могут послужить основой для разработки научно обоснованных стратегий борьбы с раком в северном регионе Казахстана. Кіріспе. Қатерлі ісік бүкіл әлемде аурушаңдық пен өлімнің негізгі себебі болып қала береді, бұл қоғамдық денсаулық...
- Open Access
- 28 February 2026
- Published by Salidat Kairbekova National Research Center for Health Development in Journal of Health Development
- Vol. 61 (1) , jhd060
Evaluation of the Effectiveness of Beck's Scale, FAS, and MHC-SF for Identifying Depressive Episodes and Post-Stroke Fatigue: A Comparative Analysis
Post-stroke fatigue and post-stroke depression are common and debilitating complications that significantly impair recovery, functional status, and quality of life in stroke survivors. However, overlapping symptoms and variability in diagnostic approaches make their accurate assessment challenging. Objective: to comparatively evaluate the reliability, validity, sensitivity, and specificity of the Beck Depression Inventory, Fatigue Assessment Scale, and Mental Health Continuum–Short Form in identifying post-stroke depression and fatigue. Methodology. A comparative literature review was conducted, including 10 peer-reviewed studies published between 2010 and 2024, selected from five major databases based on predefined inclusion criteria. The diagnostic properties of the scales (reliability, validity, sensitivity, and specificity) were systematically analyzed. Conclusions. The findings indicate that the Beck Depression Inventory demonstrates high reliability in screening for depressive symptoms, although its specificity decreases in the presence of post-stroke fatigue. The Fatigue Assessment Scale shows high accuracy in detecting fatigue but does not capture the full spectrum of psychological distress. The Mental Health Continuum–Short Form provides a comprehensive assessment of mental well-being but is less optimal for clinical diagnosis. Overall, the evidence supports a multimodal assessment approach that integrates tools for depression, fatigue, and mental well-being, improving diagnostic accuracy, guiding personalized rehabilitation, and enhancing long-term outcomes in stroke survivors.
- 28 February 2026
- Published by Salidat Kairbekova National Research Center for Health Development in Journal of Health Development
- Vol. 61 (1) , jhd060
Open AccessEvaluation of the Effectiveness of Beck's Scale, FAS, and MHC-SF for Identifying Depressive Episodes and Post-Stroke Fatigue: A Comparative Analysis
Post-stroke fatigue and post-stroke depression are common and debilitating complications that significantly impair recovery, functional status, and quality of life in stroke survivors. However, overlapping symptoms and variability in diagnostic approaches make their accurate assessment challenging. Objective: to comparatively evaluate the reliability, validity, sensitivity, and specificity of the Beck Depression Inventory, Fatigue Assessment Scale, and Mental Health Continuum–Short Form in identifying post-stroke depression and fatigue. Methodology. A comparative literature review was conducted, including 10 peer-reviewed studies published between 2010 and 2024, selected from five major databases based on predefined inclusion criteria. The diagnostic properties of the scales (reliability, validity, sensitivity, and specificity) were systematically analyzed. Conclusions. The findings indicate that the Beck Depression Inventory demonstrates high reliability in screening for depressive symptoms, although its specificity decreases in the presence of post-stroke fatigue. The Fatigue Assessment Scale shows high accuracy in detecting fatigue but does not capture the full spectrum of psychological distress. The Mental Health Continuum–Short Form provides a comprehensive assessment of mental well-being but is less optimal for clinical diagnosis. Overall, the evidence supports a multimodal assessment approach that integrates tools for depression, fatigue, and mental well-being, improving diagnostic accuracy, guiding personalized rehabilitation, and enhancing long-term outcomes in stroke survivors.
- Open Access
- 1 January 2025
- Published by Non-state educational institution "Kazakh-Russian Medical University" in Actual Problems of Theoretical and Clinical Medicine
- Vol. 50 (4)
PREDICTION OF ISCHEMIC HEART DISEASE RISK BASED ON NONLINEAR ANALYSIS OF HEART RATE VARIABILITY FROM WEARABLE DEVICE DATA
Introduction. Ischemic heart disease is one of the leading causes of mortality worldwide, highlighting the importance of implementing accessible and non-invasive screening tools at the population level. This study aimed to assess the feasibility of using heart rate variability parameters obtained from a wearable photoplethysmography-based device to evaluate the risk of ischemic heart disease. Materials and methods. A finger-worn IoT device called «Zhurek» was developed, based on photoplethysmography technology and capable of calculating real-time heart rate variability indices. The measurements obtained from «Zhurek» were compared with data from three lead Holter electrocardiographic monitoring, and machine learning algorithms were applied to datasets collected from angiographically confirmed patients and healthy volunteers. Results. The deviations between the new device measurements and Holter electrocardiography remained within clinically acceptable limits; heart rate variability parameters, particularly low-frequency power, and patient age were identified as key diagnostic indicators for detecting ischemic heart disease. Conclusion. The «Zhurek» device is suitable for large-scale ischemic heart disease risk stratification and may facilitate a shift in healthcare from a reactive, symptom-driven approach to a proactive, prevention-oriented model.
- 1 January 2025
- Published by Non-state educational institution "Kazakh-Russian Medical University" in Actual Problems of Theoretical and Clinical Medicine
- Vol. 50 (4)
Open AccessPREDICTION OF ISCHEMIC HEART DISEASE RISK BASED ON NONLINEAR ANALYSIS OF HEART RATE VARIABILITY FROM WEARABLE DEVICE DATA
Introduction. Ischemic heart disease is one of the leading causes of mortality worldwide, highlighting the importance of implementing accessible and non-invasive screening tools at the population level. This study aimed to assess the feasibility of using heart rate variability parameters obtained from a wearable photoplethysmography-based device to evaluate the risk of ischemic heart disease. Materials and methods. A finger-worn IoT device called «Zhurek» was developed, based on photoplethysmography technology and capable of calculating real-time heart rate variability indices. The measurements obtained from «Zhurek» were compared with data from three lead Holter electrocardiographic monitoring, and machine learning algorithms were applied to datasets collected from angiographically confirmed patients and healthy volunteers. Results. The deviations between the new device measurements and Holter electrocardiography remained within clinically acceptable limits; heart rate variability parameters, particularly low-frequency power, and patient age were identified as key diagnostic indicators for detecting ischemic heart disease. Conclusion. The «Zhurek» device is suitable for large-scale ischemic heart disease risk stratification and may facilitate a shift in healthcare from a reactive, symptom-driven approach to a proactive, prevention-oriented model.